公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression | JEN-CHUNG KO ; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W. | Biochemical Pharmacology | 10 | 10 | |
2020 | Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study | MENG-RUI LEE ; Huang H.-L; LUN-CHE CHEN ; HUNG-CHIH YANG ; JEN-CHUNG KO ; Cheng M.-H; Chong I.-W; LI-NA LEE ; JANN-YUAN WANG ; Dimopoulos G. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 21 | 19 | |
1994 | Superior vena cava syndrome: Rapid histologic diagnosis by ultrasound-guided transthoracic needle aspiration biopsy | JEN-CHUNG KO ; PAN-CHYR YANG ; ANG YUAN ; Chang D.-B.; CHONG-JEN YU ; HUEY-DONG WU ; LI-NA LEE ; Kuo S.-H.; KWEN-TAY LUH | American Journal of Respiratory and Critical Care Medicine | 22 | 11 | |
2010 | Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells | JEN-CHUNG KO ; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W. | Biochemical Pharmacology | 71 | 62 | |
2014 | Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells | JEN-CHANG KO ; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W. | Biochemical Pharmacology | 26 | 25 | |
2021 | Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort | SHENG-KAI LIANG ; LI-TA KENG ; CHIA-HAO CHANG ; Wen, Yueh-Feng; MENG-RUI LEE ; CHING-YAO YANG ; JANN-YUAN WANG ; JEN-CHUNG KO ; JIN-YUAN SHIH ; CHONG-JEN YU | Frontiers in Oncology | 2 | 3 | |
2017 | Tuberculosis contact investigation in an intermediate burden setting: Implications from a large tuberculosis contact cohort in Taiwan | MENG-RUI LEE ; CHENG-MAW HO ; Lee C.-H.; Lee M.-C.; LIH-YU CHANG ; KAI-LUN YU ; JEN-CHUNG KO ; JANN-YUAN WANG ; JANN-TAY WANG ; LI-NA LEE | European Respiratory Journal | 17 | 15 | |
1994 | Ultrasonographic evaluation of peridiaphragmatic lesions: A prospective study | JEN-CHANG KO ; PAN-CHYR YANG ; Chang D.-B.; CHONG-JEN YU ; LI-NA LEE ; Kuo S.-H.; KWEN-TAY LUH | Journal of Medical Ultrasound | 6 | ||
2011 | Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells | JEN-CHUNG KO ; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. | Journal of Pharmacology and Experimental Therapeutics | 19 | 20 | |
2016 | Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells | Pan, Chun-Hao; Chang, Ying-Fang; Lee, Ming-Shuo; Wen, B-Chen; JEN-CHUNG KO ; SHENG-KAI LIANG ; Liang, Mei-Chih | BMC cancer | 35 | 32 |